EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap

Ahmed A. Salman, Mohamed A. Salman

AI & Innovation · 2026

DOI: 10.1002/aiv2.70019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AI & Innovation, 2026. Verfasst von Ahmed A. Salman und 1 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endoscopic dilation is first‐line therapy for symptomatic benign esophageal strictures but remains operator‐dependent. Artificial intelligence (AI) could support assessment, risk stratification, and documentation; however, evidence from adjacent tasks is often mistaken for procedure‐specific validation.

Aim

To map the evidence for AI in benign esophageal stricture dilation, assess transferability and methodological quality, and propose a translational pathway.

Methods

We searched PubMed/MEDLINE, Scopus, and Europe PMC from inception through June 28, 2026, using prespecified searches in adults and children. Studies were classified by evidence provenance and appraised using design‐adapted domain considerations.

Results

Within the search date and eligibility criteria, no AI system was identified that guided, monitored, or assessed dilation itself; two retrospective single‐center studies applied machine learning in the target population for other tasks. Adjacent neoplasia and engineering studies support component feasibility, while clinical cohorts identify candidate predictors. Functional lumen imaging probe technology provides non‐AI measurement and potential reference labels. Recurrent concerns included selected or retrospective samples, limited external validation, and high concern about applicability to dilation. Performance cannot be transferred across mismatched target tasks, acquisition physics, reference standards, populations or operating contexts, or consequences of error.

Conclusion

Adjacent evidence can justify candidate components. Procedure‐specific calibration and validation remain necessary. Priorities are calibrated morphometric variables with prespecified reference standards and reproducible documentation using synchronized multimodal and outcome data. External validation should be followed by human‐controlled advisory testing before intraprocedural automation.

Zitieren

APA

Salman, A. A., & Salman, M. A. (2026). Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap. AI & Innovation. https://doi.org/10.1002/aiv2.70019

Vancouver

Salman AA, Salman MA. Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap. AI & Innovation. 2026. doi:10.1002/aiv2.70019

BibTeX
@article{Salman2026,
  author = {Salman, Ahmed A. and Salman, Mohamed A.},
  title = {Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap},
  journal = {AI & Innovation},
  year = {2026},
  doi = {10.1002/aiv2.70019}
}
Kostenlos starten →